%0 Published Erratum
%T Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease.
%A Kocheise L
%A Piseddu I
%A Vonderlin J
%A Tjwa ET
%A Buescher G
%A Meunier L
%A Goeggelmann P
%A Fianchi F
%A Dumortier J
%A Barciela MR
%A Gevers TJG
%A Beretta-Piccoli BT
%A Londoño MC
%A Frankova S
%A Roesner T
%A Joerg V
%A Schmidt C
%A Glaser F
%A Sutter JP
%A Fründt TW
%A Lohse AW
%A Huber S
%A von Felden J
%A Sebode M
%A Schulze K
%J Front Immunol
%V 15
%N 0
%D 2024
%M 38327519
%F 8.786
%R 10.3389/fimmu.2024.1369747
%X [This corrects the article DOI: 10.3389/fimmu.2023.1326078.].